Company profile

PFE stock data

(
)

Calendar

6 Aug 20
29 Oct 20
31 Dec 20

News

Quarter (USD) Jun 20 Mar 20 Sep 19 Jun 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 19 Dec 18 Dec 17 Dec 16
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Pfizer earnings reports.

Date Owner Security Transaction Code 10b5-1 $Price #Shares $Value #Remaining
15 Oct 20 Albert Bourla Phantom Stock Units SSP Common Stock Grant Aquire A No 36.55 13 475.15 78,638
15 Oct 20 John D Young Phantom Stock Units SSP Common Stock Grant Aquire A No 36.55 12 438.6 47,342
15 Oct 20 Rady A Johnson Phantom Stock Units SSP Common Stock Grant Aquire A No 36.55 4 146.2 5,664
15 Oct 20 Jennifer B. Damico Phantom Stock Units SSP Common Stock Grant Aquire A No 36.55 32 1.17K 10,668
12 Oct 20 John D Young Phantom Stock Units SSP Common Stock Grant Aquire A No 36.82 40 1.47K 47,328
69.6% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 2368 2374 -0.3%
Opened positions 148 116 +27.6%
Closed positions 154 210 -26.7%
Increased positions 1026 965 +6.3%
Reduced positions 959 1092 -12.2%
13F shares
Current Prev Q Change
Total value 1.44T 1.38T +4.1%
Total shares 3.87B 3.91B -1.1%
Total puts 37.8M 34.5M +9.5%
Total calls 24.21M 24.3M -0.3%
Total put/call ratio 1.6 1.4 +9.9%
Largest owners
Shares Value Change
Vanguard 456.89M $14.94B -1.1%
BLK BlackRock 427.53M $13.98B +0.8%
STT State Street 298.9M $9.77B +2.1%
Wellington Management 250.85M $8.2B +14.7%
Capital World Investors 244.44M $7.99B +8.7%
Geode Capital Management 89.14M $2.91B -0.9%
BAC Bank of America 78.41M $2.56B -9.5%
NTRS Northern Trust 68.73M $2.25B -1.8%
BK Bank of New York Mellon 57.11M $1.87B +1.8%
State Farm Mutual Automobile Insurance 56.54M $1.85B 0.0%
Largest transactions
Shares Bought/sold Change
Wellington Management 250.85M +32.18M +14.7%
Capital World Investors 244.44M +19.63M +8.7%
JPM JPMorgan Chase & Co. 40.28M -14.1M -25.9%
Nuveen Asset Management 31.89M -8.86M -21.7%
Nordea Investment Management Ab 22.27M +8.8M +65.3%
BAC Bank of America 78.41M -8.26M -9.5%
Citadel Advisors 1.17M -7M -85.6%
STT State Street 298.9M +6.28M +2.1%
BEN Franklin Resources 33.97M +5.51M +19.4%
TD Asset Management 5.08M -5.47M -51.8%
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: AAH, adapted, addressing, Adjuvant, Agent, Albert, automatically, besylate, blinded, Bourla, BRIGHT, broadly, chose, cohort, Cortexyme, cyber, daunorubicin, deeply, Diflucan, dispense, dispensed, dispensing, ehf, England, epidemiological, faith, febrile, fewer, futility, glycoprotein, GmbH, good, gradual, gradually, guarantor, heard, hearing, inconsistent, insulin, intermediary, journal, lifesaving, Lightspeed, loan, London, malware, manifested, maternal, meningococcal, mentioned, messenger, Mexico, misrepresented, mobility, myelosuppressive, Neisseria, Neratinib, neuropathic, neutralizing, neutropenia, NHS, notice, Nyvepria, partnership, peer, phishing, precedent, preclinical, pregabalin, proven, PTC, Puma, RAR, ready, Reddy, regimen, RET, RNA, RSV, safe, sampling, schedule, Scotland, Scottish, SE, Shanghai, shorter, skin, spike, statutory, steady, syncytial, Trump, UK, unconditionally, unnecessary, vitro, withdrawn, young, Zoloft
Removed: acute, aged, alectinib, ALK, Amneal, amyloid, artificially, Authorisation, autonomy, Avastin, Avillion, azacitidine, Baxter, begin, Ben, bevacizumab, Biotech, capture, cardiovascular, catch, category, Celltrion, ceritinib, cervical, CMA, comprised, consistently, crizotinib, culture, declared, Eurohealth, familial, fine, Genentech, germline, Gland, glioblastoma, Hengrui, Hikma, HR, induction, informed, Janssen, Jiangsu, Kabi, leaving, letter, Lorviqua, media, meglumine, modest, monotherapy, myeloid, NDA, neck, negotiating, Orion, OTC, output, overturned, persistent, pertaining, phenytoin, PLC, polyneuropathy, Precedex, premix, recurrent, retain, saline, Sarl, setting, sodium, solution, spinoff, split, susceptibility, TKI, Tribunal, unresectable, vaccinated, Venue, voluntarily, write, Zirabev